Physiomics presentation at Bi

RNS Number : 2015I

Physiomics PLC

17 November 2008

 



Physiomics plc

The Magdalen Centre

The Oxford Science Park
Robert Robinson Avenue
Oxford

OX4 4GA
UK

Tel [phone]

Fax [phone]

17 November 2008            

Physiomics plc ('Physiomics' or 'the Company')

Physiomics to present Physiomics' technology at the Bio-Europe Conference

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it will be participating in the 2008 Bio-Europe 14th Annual International Partnering Conference, taking place at the Mannheim Congress Centre on 17-19 November 2008. Dr Christophe Chassagnole, Chief Operating Officer of Physiomics, will give an update on the Company's activities and recent progress. The presentation will be a part of the Enabling Technologies track, scheduled at 10:45 am on Wednesday 19 November.

More information about the conference may be found at www.ebdgroup.com/bioeurope

For further information:

Physiomics plc                                                    [phone]

Dr Christophe Chassagnole, COO 

E-mail: [e-mail]

Grant Thornton Corporate Finance                       [phone]

Philip Secrett, Colin Aaronson

About Physiomics plc

Physiomics plc (AIM:PYC) is a computational systems biology services company applying simulations of cell behaviour to drug development to reduce the high attrition rates of clinical trials. As 80-90 per cent of all clinical drug candidates fail to reach the market, estimates1 show that an overall ten per cent improvement in success rates could reduce the cost of one drug's development by as much as $242 million, from the current estimate of around $800 million.

Physiomics develops computational systems biology models to predict and understand cancer drug efficacy from pre-clinical research to clinical development. Physiomics has created detailed mathematical models incorporating most important molecular events taking place during the human cell cycle and apoptosis processes. Physiomics developed SystemCell® technology, a multi-cellular environment software, which enables the simulation of population of 'virtual cells'.

Physiomics, based in Oxford, UK, was founded in 2001, and floated on AIM in 2004. For further information, please visit www.physiomics-plc.com

SystemCell® is a registered trademark of Physiomics plc

1Tufts Centre Impact Report 2002

 

END

 

 

NRAFKQKBBBDDFDD